October 26, 2021 • 12:00 PM - 3:00 PM ET

Michael McCaughan is a founding member of Prevision Policy LLC, a leading provider of regulatory and reimbursement policy analysis for the biopharma industry. He was previously the Editor-In-Chief of The Pink Sheet and remains a contributor to the publication. McCaughan speaks frequently on regulatory, reimbursement and policy developments affecting the biopharmaceutical industry.

Prevision Policy, founded in 2010, provides health care policy analysis to advance the mutual understanding among policymakers, business executives and the investment community, in the belief that a deeper understanding of policy leads to better business, and a deeper understanding of business leads to better policy.

Ted Slafsky is one of the nation’s leading experts on health care policy, pharmaceutical pricing, the hospital industry and health care access. Based in Washington, D.C., he is Founder and Principal of Wexford Solutions LLC where he consults with businesses and non-profits looking to strengthen their position in the marketplace and improve health care outcomes.

Mr. Slafsky is also the Publisher and CEO of 340B Report, the only subscription-based news service covering developments in the federal 340B drug pricing progam.

Mr. Slafsky speaks at industry conferences and events. Clients include established firms, health care start-ups, health care institutions and non-profits. Mr. Slafsky is frequently quoted in the news and is one of the nation’s leading experts on pharmaceutical and health care matters impacting low-income and other vulnerable patient populations. His opinion pieces have been published in various national publications including USA Today Health Affairs, The Hill and Roll Call. Mr. Slafsky has excellent bipartisan relations with Congress and the administration. He also has close relationships with many leading hospital executives, pharmacy directors and pharmacy industry leaders.

Prior to his new venture, Mr. Slafsky served as President and Chief Executive Officer of 340B Health, a Washington D.C.-based association of over 1400 hospitals nationwide participating in the federal 340B drug discount program. The program enables hospitals and clinics serving large numbers of low-income patients to stretch scarce resources and expand access to care. It is a critically important program for hospitals, community health centers, Ryan White clinics and other providers serving vulnerable patient populations. Thanks to the program, patients are able to access affordable medications and improved health care. Mr. Slafsky served as President and CEO of the organization from 2010-2018. From 1996-2010, he was Executive Director. During his tenure, he grew 340B Health’s membership from 50 hospitals to over 1300 hospitals and increased its budget from $50,000 to over $10 million. He also oversaw its growth from 2 employees to over 30, as well as oversaw the work of 10 prominent consultants including former U.S. lawmakers from both parties.

Mr. Slafsky directed and oversaw two national conferences that grew in size for 22 years straight, along with 10 regional roundtables per year that brought together the various stakeholders in the 340B program. Mr. Slafsky oversaw a team of government relations specialists, attorneys, policy analysts, writers and pharmacists who advocate on behalf of member hospitals and provide compliance guidance. Mr. Slafsky helped conceive and oversaw various communications resources including the widely-read blog 340B Informed and the member-only electronic news service–The Bulletin. He was the Co-Founder and Editor-in-Chief of the Drug Discount Monitor.

Prior to his time at 340B Health, Mr. Slafsky was a Health Policy Fellow for the U.S. Senate Democratic Policy Committee. He assisted Senate Majority Leader George Mitchell and Senate Democratic Policy Director Tom Daschle on messaging during the Clinton health reform debate. From 1990-1993, Mr. Slafsky was a Reporter and Researcher at U.S. News & World Report where he reported on politics, health and education policy. He also served as the editorial assistant to David Gergen, the magazine’s editor at large and advisor to four U.S. Presidents. Mr. Slafsky was the winner, with a team of U.S. News journalists, of the Overseas Press Club’s Hallie and Whit Burnett Award.

Mr. Slafsky has a Master of Public Policy from Duke University and Bachelor of Science in Political Science from Tufts University where he graduated Magna Cum Laude.

Ted lives in Northern Virginia with his wife Diane and two children.

Peggy Tighe deciphers and interprets highly complex healthcare matters and translates them into action. She teams with health systems, patient groups, and provider organizations to develop persuasive policy arguments and strategies to influence Congress and relevant agencies, creating change to protect and support providers and the patients they serve.

Peggy focuses her practice on lobbying, coalition building, crafting and implementing grass roots campaigns, and coordinating media relations. A dynamic and entertaining speaker, she is well versed on giving congressional and policy updates on subjects such as Affordable Care Act implementation, Medicare provider reimbursement including SGR reform, hospital wage index, nursing payments, Social Security disability, patient safety, medical liability reform, Long Term Acute Care Hospital and clinical laboratory policy, hunger and nutrition, and patient-focused pharmaceutical policy.

Peggy has spent her career understanding the complex policy problems that health systems, patient groups and provider organizations face, and influencing federal policy and decision making on their behalf. Peggy’s prior experience in healthcare lobbying and policy with two highly visible, national healthcare associations, the American Medical Association and the Health Insurance Association of America, as well as with dozens of national coalitions and individual clients, make her unique in this space.

Peggy has built and actively nurtures contacts and relationships on both sides of the political aisle, focusing her efforts on finding the right policy solution. She served as AMA’s lead lobbyist and primary contact with House Republican leadership, the House Energy and Commerce Committee, and some 80 Congressional assignments including the majority of physician members of Congress. She also works closely with the House Ways and Means committee, Senate Finance committee, and other relevant healthcare committees on both sides of the aisle.

Described by clients, Congressional staff, colleagues and contacts as “incredibly responsive” and “a team player”, Peggy devotes enormous effort to ensuring that clients never wonder about her activity and commitment, that members and their staff always have the tools and information they need to support their decision-making, and that her strong relationships on Capitol Hill result in direct benefits to clients. Yet, she’s never too busy to offer assistance, mentoring or guidance to her own team, Hill staffers, or other government relations professionals, as evidenced by her role as past President of Women in Government Relations, a non-partisan government relations association in the Washington metropolitan area and her award as Mentor of the Year from the Public Leadership Education Network.

Additionally, Peggy has:

• Coordinated the activities of a hospital coalition that obtained more than $3 billion over a five-year period to implement beneficial changes to members’ Medicare area wage index classifications.
• Led a coalition of five New Orleans area hospitals in the aftermath of Hurricane Katrina, securing hundreds of millions of dollars in federal funding to ensure that the hospitals were able to remain open and serve the community.
• Effectively lobbied to persuade three U.S. Senators to break with their party on three occasions to vote in support of the AMA-backed Patients Bill of Rights in 1999.
• Lead lobbyist for House victories on the Medicare Fee Schedule, Medical Liability Reform, Patients’ Bill of Rights, and Antitrust Relief, key issues of great importance to the medical community.
• Directed and coordinated the activities of six field directors in the Health Insurance Association of America’s priority states during the successful "Harry and Louise" national healthcare reform campaign. Strategized and implemented many of the federal grassroots activities in this campaign, including grasstops (high-level grassroots), coalition building, letter writing, and database building.

Larry Crowder has worked in the 340B industry sine 2005. He received his Bachelor of Business from Texas A&M.; Prior to taking on the 340B responsibility he gained sales management and pharmacy operations experience in locally owned hospital systems with Cervey’s parent company Morris & Dickson.

Larry Crowder has overseen the expansion of 340B pharmacy services and distribution service offerings for Cervey. He has been integral to the creation and development of 340B Split Bill software. With over 15 years in pharmacy services, Larry has assisted countless pharmacies through implementation of cutting edge software designed to advance pharmacy operations in a wide number of areas, including 340b compliance and optimization. Currently, he is a member of the Apexus Faculty and routinely speaks at Apexus 340B University regarding the Wholesalers role in 340B. Additionally, Larry has extensive experience consulting in other areas of pharmacy supply chain including; asset management, procurement processes, formulary management, and pharmacy accounting practices.

Larry's immediate goal is to continue his leadership in Cervey’s continuous development of innovative 340b IT solutions and provide high levels of customer facing support which meet today’s most significant challenges.